5-year quality of life study of the SUPREMO trial examining chest wall radiotherapy in patients with intermediate-risk breast cancer with Professor Galina Velikova
About this episode
This episode discusses a 5-year quality of life study from the SUPREMO trial focusing on chest wall radiotherapy in intermediate-risk breast cancer patients.
5-year quality of life (QOL) substudy of the SUPREMO trial examining the effects of chest wall radiotherapy versus no chest wall radiotherapy after mastectomy in patients with intermediate-risk breast cancer. The data will put patients in a better position to make an informed treatment decision considering long-term QOL effects for intermediate-risk early breast cancer. Click here to read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00122-1/fulltext
More episodes of The Lancet Oncology in conversation with
Explore listener stats, chart rankings, contacts and more on the The Lancet Oncology in conversation with podcast page.